| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/10/2007 | CN1293880C Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 01/10/2007 | CN1293867C Medicinal compound preparation |
| 01/09/2007 | US7160992 Amino-modified polysaccharides and methods of generating and using same |
| 01/09/2007 | US7160988 Altering protein functional properties through terminal fusions |
| 01/09/2007 | US7160924 polyacetal-protein conjugates which demonstrate advantages in bioavailability and biocompatibility compared to unconjugated proteins, without any undesirable side effects e.g., kidney vacuole formation |
| 01/09/2007 | US7160923 Polyamine analogues as therapeutic and diagnostic agents |
| 01/09/2007 | US7160862 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash or gum patch |
| 01/09/2007 | US7160726 Compositions comprising conditioned cell culture media and uses thereof |
| 01/09/2007 | US7160559 Galantamine hydrobromide particles and a water soluble film forming polymer are layered or coated on inert spheres, covered by a release rate controlling membrane made of a water insoluble polymer and optionally a plasticizer; galantamine and water-soluble polymer topcoat |
| 01/09/2007 | US7160558 Coating and binding agent for pharmaceutical formulations with improved storage stability |
| 01/09/2007 | US7160557 Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 01/09/2007 | US7160554 Enhanced circulation effector composition and method |
| 01/09/2007 | US7160551 Nonaqueous biocompatible solvent, a biodegradable hydrophobic polymer, and an amphiphilic block copolymer such as ethylene oxide-propylene oxide triblock copolymer; use as an injectable implant; no initial "burst" |
| 01/09/2007 | US7160538 Employing 1,1,1,2,3,3,3-heptafluoropropane as the sole propellant gas for administration of micronized or powdered drugs by inhalation |
| 01/09/2007 | US7160536 Radiolabelled metal transport proteins as imaging agents |
| 01/09/2007 | US7160466 Uses of cucurbituril devices |
| 01/09/2007 | CA2467490C Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 01/09/2007 | CA2375372C Mutual prodrugs of amlodipine and atorvastatin |
| 01/09/2007 | CA2364617C Method for the reductive amination of polysaccharides |
| 01/09/2007 | CA2343376C Sustained release ranolazine formulations |
| 01/09/2007 | CA2340056C Pharmaceutical compositions containing lipase inhibitors |
| 01/09/2007 | CA2308520C Strictly alternating poly(alkylene oxide ether) copolymers |
| 01/09/2007 | CA2301165C In situ formation of polymeric material |
| 01/09/2007 | CA2295177C Drug targeting system, method of its preparation and its use |
| 01/09/2007 | CA2294172C Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration |
| 01/09/2007 | CA2294033C Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
| 01/09/2007 | CA2269519C Acylated cyclodextrin derivatives |
| 01/09/2007 | CA2251702C Biologically active composition |
| 01/09/2007 | CA2210985C Pharmaceutical composition containing fenofibrate and polyglycolized glycerides |
| 01/09/2007 | CA2169831C Cosmetic melanins |
| 01/09/2007 | CA2142126C Inhalation powder containing antistatic agent |
| 01/04/2007 | WO2007002837A2 Methods and compositions for the prevention and treatement of inflammatory disease |
| 01/04/2007 | WO2007002780A2 Topical preservative compositions |
| 01/04/2007 | WO2007002709A2 Complexation of metal ions with polypeptides |
| 01/04/2007 | WO2007002482A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 01/04/2007 | WO2007002345A2 Method for improving water solubility of chitosan |
| 01/04/2007 | WO2007002233A2 Low-toxicity, long-circulating chimeras of human interferon- alpha analogs and interferon tau |
| 01/04/2007 | WO2007002222A2 Psma antibody-drug conjugates |
| 01/04/2007 | WO2007002145A2 Lysozyme-based food stuff |
| 01/04/2007 | WO2007001851A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/04/2007 | WO2007001744A2 Methods and compositions for enhancing vascular access |
| 01/04/2007 | WO2007001506A1 Composition and method of protection against uv irradiation |
| 01/04/2007 | WO2007000939A1 Therapeutic agent for local inflammation |
| 01/04/2007 | WO2007000842A1 Granule dispersion composition, process for producing the same, and granular material and medicine |
| 01/04/2007 | WO2007000671A2 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 01/04/2007 | WO2007000472A1 Self-sterilizing products |
| 01/04/2007 | WO2007000192A1 Topical compositions comprising nanoparticles of an isoflavone |
| 01/04/2007 | WO2007000163A1 Immobilisation of polypeptides by irradiation |
| 01/04/2007 | WO2006124630A3 Compositions and methods for enhancing the efficacy of vaccines |
| 01/04/2007 | WO2006106521A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
| 01/04/2007 | WO2006073493A3 Vaccine conjugates comprising a monoclonal antibody binding to human dentritic cells and beta human chronic gonadotropin |
| 01/04/2007 | WO2006059106A3 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy |
| 01/04/2007 | WO2006043083A3 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy |
| 01/04/2007 | WO2005112888A8 Methods for making injectable polymer hydrogels |
| 01/04/2007 | WO2005074546A3 Modified human growth hormone polypeptides and their uses |
| 01/04/2007 | WO2005035572A3 Antibody compositions and methods |
| 01/04/2007 | WO2005015158A3 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 01/04/2007 | US20070005130 Biodegradable polymer for coating |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004904 G-csf conjugates |
| 01/04/2007 | US20070004694 Estrogen compositions for vaginal administration |
| 01/04/2007 | US20070004693 Estrogen compositions for vaginal administration |
| 01/04/2007 | US20070004668 Antisense permeation enhancers |
| 01/04/2007 | US20070004667 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004665 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004664 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004663 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 01/04/2007 | US20070004649 Anti-influenza virus compound comprising biflavonoid-sialic acid glycoside |
| 01/04/2007 | US20070004631 Method for synthesis of phospholipids-PEG-biomolecule conjugates |
| 01/04/2007 | US20070003630 Anti-angiogenic compositions and methods of use |
| 01/04/2007 | US20070003629 Anticancer agents; prevent forming blood vessels; removal blockage |
| 01/04/2007 | US20070003627 Hemorrhoidal compositions and method of use |
| 01/04/2007 | US20070003626 Sterile in-situ microcarrier forming gelled polymeric dispersions and processes to manufacture the same |
| 01/04/2007 | US20070003620 Morphine sulfate microgranules, method for preparing same and compositions containing same |
| 01/04/2007 | US20070003614 Pharmaceutical compositions comprising active vitamin D compounds |
| 01/04/2007 | US20070003602 Method of extracting proteins from a cell |
| 01/04/2007 | US20070003601 Quick water-dissolving edible anti-hunger film containing fibres that swell in the presence of water |
| 01/04/2007 | US20070003600 Methods for reducing c-reactive protein |
| 01/04/2007 | US20070003598 Osteogenic implants for soft tissue |
| 01/04/2007 | US20070003592 Biodegradable phase separated segmented multi block co-polymers |
| 01/04/2007 | US20070003566 Polyepitope carrier protein |
| 01/04/2007 | US20070003502 Skin preparation for external use characterized by containing sugar derivative of alpha, alpha-trehalose |
| 01/04/2007 | US20070003492 Porous silica having substance carried thereon |
| 01/04/2007 | US20070003491 administering polylysine to mammals as dietetics, for prevention and/or treatment of obesity |
| 01/04/2007 | US20070003488 Methods of preparing a foam comprising a sclerosing agent |
| 01/04/2007 | US20070003487 Composition, method and pharmaceutical preparation for pharmaceutical spray suspensions |
| 01/04/2007 | US20070003485 Microbubble-generating carbohydrate microparticles encapsulated in biodegradable, crosslinked protein shells for enhanced echocardiographic imaging |
| 01/04/2007 | DE112004002099T5 Anionen bindende Polymere und Verwendungen davon Anion-binding polymers and uses thereof |
| 01/04/2007 | DE102005030492A1 Intravascular echo contrast agents, useful as clinical diagnostics in imaging techniques, comprises an aqueous based poloxamer preparation |
| 01/04/2007 | CA2613803A1 Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for treatment of cardiovascular disease |
| 01/04/2007 | CA2613647A1 Self-sterilizing products comprising a polymer bound to a phthalocyanine derivative |
| 01/04/2007 | CA2612901A1 Low-toxicity, long-circulating chimeras of human interferon- alpha analogs and interferon tau |
| 01/04/2007 | CA2612762A1 Psma antibody-drug conjugates |
| 01/04/2007 | CA2612751A1 Vegf-containing transport media composition for storing cells engrafted in a biocompatible matrix |
| 01/04/2007 | CA2612486A1 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 01/04/2007 | CA2611266A1 Use of conjugates with linkers cleavable by photodissociation or fragmentation for mass spectrometry analysis of tissue sections |
| 01/03/2007 | EP1739097A1 Hyaluronic acid/methotrexate compound |
| 01/03/2007 | EP1738770A1 Method for synthesis of phospholipids-PEG-biomolecule conjugates |
| 01/03/2007 | EP1738769A1 Preparation for transferring nucleic acid into cell |
| 01/03/2007 | EP1738768A1 Aqueous formulation for vecuronium bromide |